179 related articles for article (PubMed ID: 23115650)
1. A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines.
van Hoek AJ; Ngama M; Ismail A; Chuma J; Cheburet S; Mutonga D; Kamau T; Nokes DJ
PLoS One; 2012; 7(10):e47511. PubMed ID: 23115650
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
Villanueva-Uy MET; Lam HY; Aldaba JG; Uy TMZ; Valverde HA; Silva MWT; Mooney J; Clark A; Pecenka C
Vaccine; 2021 Nov; 39(48):7091-7100. PubMed ID: 34753614
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
Wu CL; Yang YC; Huang LM; Chen KT
Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
[TBL] [Abstract][Full Text] [Related]
4. Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway.
Hansen Edwards C; de Blasio BF; Salamanca BV; Flem E
PLoS One; 2017; 12(8):e0183306. PubMed ID: 28817621
[TBL] [Abstract][Full Text] [Related]
5. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of rotavirus vaccination in Mozambique.
Lourenço Guimarães E; Chissaque A; Pecenka C; Clark A; Vaz B; Banze A; Canana N; Romão C; do Rosário Oliveira Martins M; de Deus N; Debellut F
Vaccine; 2022 Aug; 40(36):5338-5346. PubMed ID: 35933279
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option.
Cui S; Tobe RG; Mo X; Liu X; Xu L; Li S
BMC Infect Dis; 2016 Nov; 16(1):677. PubMed ID: 27846803
[TBL] [Abstract][Full Text] [Related]
10. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
Debellut F; Jaber S; Bouzya Y; Sabbah J; Barham M; Abu-Awwad F; Hjaija D; Ramlawi A; Pecenka C; Clark A; Mvundura M
PLoS One; 2020; 15(2):e0228506. PubMed ID: 32023295
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand.
Luangasanatip N; Mahikul W; Poovorawan K; Cooper BS; Lubell Y; White LJ; Teerawattananon Y; Pan-Ngum W
Vaccine; 2021 Mar; 39(9):1402-1414. PubMed ID: 33531197
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of the introduction of rotavirus vaccine in Hong Kong.
Yeung KHT; Lin SL; Clark A; McGhee SM; Janusz CB; Atherly D; Chan KC; Nelson EAS
Vaccine; 2021 Jan; 39(1):45-58. PubMed ID: 33221066
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
[TBL] [Abstract][Full Text] [Related]
14. [A cost-effectiveness analysis on universal infant rotavirus vaccination strategy in China].
Sun SL; Gao YQ; Yin J; Zhuang GH
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):238-42. PubMed ID: 26917523
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
[TBL] [Abstract][Full Text] [Related]
16. The cost effectiveness of rotavirus vaccination in Iran.
Mousavi Jarrahi Y; Zahraei SM; Sadigh N; Esmaeelpoor Langeroudy K; Khodadost M; Ranjbaran M; Sanjari Moghaddam A; Besharat M; Mosavi Jarrahi A
Hum Vaccin Immunother; 2016 Mar; 12(3):794-800. PubMed ID: 26360331
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
[TBL] [Abstract][Full Text] [Related]
18. Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs.
Wang J; Zhang H; Zhang H; Fang H
Hum Vaccin Immunother; 2022 Dec; 18(7):2090162. PubMed ID: 35816415
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico.
Gomez J; Velázquez FR; Guzman-Holst A; Cervantes Apolinar MY; Van Bellinghen LA; Van Vlaenderen I; van Oorschot D
Hum Vaccin Immunother; 2023 Aug; 19(2):2219189. PubMed ID: 37339232
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of rotavirus vaccination in children of Bhutan.
Pempa ; Luz ACG; Luangasanatip N; Kingkaew P; Adhikari D; Isaranuwatchai W; Choiphel D; Pecenka C; Debellut F
Vaccine; 2020 Jul; 38(32):5049-5059. PubMed ID: 32522415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
